Imaging diagnosis, pathological upgrade, and imaging technology progress of ductal carcinoma in situ of the breast

VernacularTitle:乳腺导管原位癌影像学诊断、病理学升级及影像学技术进展
Author: Lili ZHANG ¹ ; Ru TAN ; Xueli FANG ; Yu YANG ; Zheng SANG ; Baosheng LI
Author Information

1. 山东第一医科大学附属肿瘤医院放疗科，济南　250117
Keywords: Carcinoma, intraductal, noninfiltrating; Imaging diagnosis; Pathology upgrade
From: Journal of International Oncology 2024;51(3):166-169
CountryChina
Language:Chinese
Abstract: Ductal carcinoma in situ of the breast (DCIS) most commonly manifests as asymptomatic calcifications at mammography. The most common manifestation of MRI is nonmass enhancement. The ultrasound mainly presents as a hypoechoic irregular hypervascular mass without posterior features. Core-needle biopsy is a commonly used method for preoperative diagnosis of DCIS. Due to differences in needle type and sample size, there is a certain degree of pathological upgrading of the lesion. In recent years, there has been controversy over the diagnosis and treatment of DCIS. With the development of breast disease diagnostic technology, advances in digital breast tomography, artificial intelligence, and radiomics are expected to help DCIS management and address issues such as overdiagnosis.